Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

The use of platelet-rich plasma in management of musculoskeletal pain: a narrative review

  • Thu, Aung Chan (Department of Physical Medicine and Rehabilitation, University of Medicine)
  • Received : 2022.04.26
  • Accepted : 2022.05.17
  • Published : 2022.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Musculoskeletal pain is the most common pain reported by patients. Platelet-rich plasma (PRP) is widely used to treat musculoskeletal pain. However, the efficacy of PRP to treat this pain remains controversial. This review highlights the application of PRP in the treatment of musculoskeletal pain. PRP treatment appears to reduce pain and improve function in patients with musculoskeletal pain. However, there are limitations to the currently published studies. These limitations include the PRP preparation methods, type of activators, types of pathology to be treated, methods and times of administration, and association of PRP with other treatments.

Keywords

References

  1. Casser HR, Schaible HG. Musculoskeletal pain. Schmerz 2015;29:486-8, 490-5. https://doi.org/10.1007/s00482-015-0046-9
  2. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
  3. Marks R. Qigong and musculoskeletal pain. Curr Rheumatol Rep 2019;21:59. https://doi.org/10.1007/s11926-019-0861-6
  4. Hawker GA. The assessment of musculoskeletal pain. Clin Exp Rheumatol 2017;35(5 Suppl 107):8-12.
  5. Sepulveda F, Baerga L, Micheo W. The role of physiatry in regenerative medicine: the past, the present, and future challenges. PM R 2015;7(4 Suppl):S76-80. https://doi.org/10.1016/j.pmrj.2015.01.004
  6. Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J 2012;32:150-63.
  7. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord 2018;4:18-24. https://doi.org/10.1159/000477353
  8. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet 2018;35:753-6. https://doi.org/10.1007/s10815-018-1159-8
  9. Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg 2016;42:491-7. https://doi.org/10.1097/DSS.0000000000000665
  10. Cao Y, Zhu X, Zhou R, He Y, Wu Z, Chen Y. A narrative review of the research progress and clinical application of platelet-rich plasma. Ann Palliat Med 2021;10:4823-9. https://doi.org/10.21037/apm-20-2223
  11. Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci 2020;21:7794. https://doi.org/10.3390/ijms21207794
  12. Linden MD. Platelet physiology. Methods Mol Biol 2013;992:13-30. https://doi.org/10.1007/978-1-62703-339-8_2
  13. Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther 2014;16:204. https://doi.org/10.1186/ar4493
  14. Wu CC, Chen WH, Zao B, Lai PL, Lin TC, Lo HY, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 2011;32:5847-54. https://doi.org/10.1016/j.biomaterials.2011.05.002
  15. Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 2010;225:757-66. https://doi.org/10.1002/jcp.22274
  16. Solakoglu O, Heydecke G, Amiri N, Anitua E. The use of plasma rich in growth factors (PRGF) in guided tissue regeneration and guided bone regeneration: a review of histological, immunohistochemical, histomorphometrical, radiological and clinical results in humans. Ann Anat 2020;231:151528. https://doi.org/10.1016/j.aanat.2020.151528
  17. Gautam VK, Verma S, Batra S, Bhatnagar N, Arora S. Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: clinical and ultrasonographic evaluation. J Orthop Surg (Hong Kong) 2015;23:1-5. https://doi.org/10.1177/230949901502300101
  18. Kaushik A, Kumaran MS. Platelet-rich plasma: the journey so far! Indian Dermatol Online J 2020;11:685-92. https://doi.org/10.4103/idoj.IDOJ_369_19
  19. Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy: future or trend? Arthritis Res Ther 2012;14:219. https://doi.org/10.1186/ar3914
  20. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323-30. https://doi.org/10.1136/annrheumdis-2013-204763
  21. Bliddal H. Definition, pathology and pathogenesis of osteoarthritis. Ugeskr Laeger 2020;182:V06200477.
  22. Block JA, Cherny D. Management of knee osteoarthritis: what internists need to know. Med Clin North Am 2021;105:367-85. https://doi.org/10.1016/j.mcna.2020.10.005
  23. Cugat R, Cusco X, Seijas R, Alvarez P, Steinbacher G, Ares O, et al. Biologic enhancement of cartilage repair: the role of platelet-rich plasma and other commercially available growth factors. Arthroscopy 2015;31:777-83. https://doi.org/10.1016/j.arthro.2014.11.031
  24. Anitua E, Sanchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 2007;46:1769-72. https://doi.org/10.1093/rheumatology/kem234
  25. Sun SF, Lin GC, Hsu CW, Lin HS, Liou IS, Wu SY. Comparing efficacy of intraarticular single crosslinked Hyaluronan (HYAJOINT Plus) and platelet-rich plasma (PRP) versus PRP alone for treating knee osteoarthritis. Sci Rep 2021;11:140. https://doi.org/10.1038/s41598-020-80333-x
  26. Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med 2018;11:583-92. https://doi.org/10.1007/s12178-018-9524-x
  27. Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res 2017;12:16. https://doi.org/10.1186/s13018-017-0521-3
  28. Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med 2021;49:249-60. https://doi.org/10.1177/0363546520909397
  29. Zhao J, Huang H, Liang G, Zeng LF, Yang W, Liu J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord 2020;21:224. https://doi.org/10.1186/s12891-020-03262-w
  30. McLarnon M, Heron N. Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis. BMC Musculoskelet Disord 2021;22:550. https://doi.org/10.1186/s12891-021-04308-3
  31. Repetto I, Biti B, Cerruti P, Trentini R, Felli L. Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery? J Foot Ankle Surg 2017;56:362-5. https://doi.org/10.1053/j.jfas.2016.11.015
  32. Paget LD, Reurink G, de Vos RJ, Weir A, Moen MH, Bierma-Zeinstra SM, et al. Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial. JAMA 2021;326:1595-605. https://doi.org/10.1001/jama.2021.16602
  33. Godoy-Santos AL, Fonseca LF, de Cesar Netto C, Giordano V, Valderrabano V, Rammelt S. Ankle osteoarthritis. Rev Bras Ortop (Sao Paulo) 2020;56:689-96.
  34. Vannabouathong C, Del Fabbro G, Sales B, Smith C, Li CS, Yardley D, et al. Intra-articular injections in the treatment of symptoms from ankle arthritis: a systematic review. Foot Ankle Int 2018;39:1141-50. https://doi.org/10.1177/1071100718779375
  35. Derwich M, Mitus-Kenig M, Pawlowska E. Interdisciplinary approach to the temporomandibular joint osteoarthritis-review of the literature. Medicina (Kaunas) 2020;56:225. https://doi.org/10.3390/medicina56050225
  36. Zotti F, Albanese M, Rodella LF, Nocini PF. Platelet-rich plasma in treatment of temporomandibular joint dysfunctions: narrative review. Int J Mol Sci 2019;20:277. https://doi.org/10.3390/ijms20020277
  37. Li FL, Wu CB, Sun HJ, Zhou Q. Comparison of autologous platelet-rich plasma and chitosan in the treatment of temporomandibular joint osteoarthritis: a retrospective cohort study. J Oral Maxillofac Surg 2021;79:324-32. https://doi.org/10.1016/j.joms.2020.09.016
  38. Sousa BM, Lopez-Valverde N, Lopez-Valverde A, Caramelo F, Fraile JF, Payo JH, et al. Different treatments in patients with temporomandibular joint disorders: a comparative randomized study. Medicina (Kaunas) 2020;56:113. https://doi.org/10.3390/medicina56030113
  39. Bousnaki M, Bakopoulou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac Surg 2018;47:188-98. https://doi.org/10.1016/j.ijom.2017.09.014
  40. Haigler MC, Abdulrehman E, Siddappa S, Kishore R, Padilla M, Enciso R. Use of platelet-rich plasma, platelet-rich growth factor with arthrocentesis or arthroscopy to treat temporomandibular joint osteoarthritis: systematic review with meta-analyses. J Am Dent Assoc 2018;149:940-52. https://doi.org/10.1016/j.adaj.2018.07.025
  41. Knezevic NN, Candido KD, Vlaeyen JW, Van Zundert J, Cohen SP. Low back pain. Lancet 2021;398:78-92. https://doi.org/10.1016/S0140-6736(21)00733-9
  42. Chou R. Low back pain. Ann Intern Med 2021;174:ITC113-28. https://doi.org/10.7326/AITC202108170
  43. Xuan Z, Yu W, Dou Y, Wang T. Efficacy of platelet-rich plasma for low back pain: a systematic review and meta-analysis. J Neurol Surg A Cent Eur Neurosurg 2020;81:529-34. https://doi.org/10.1055/s-0040-1709170
  44. Sanapati J, Manchikanti L, Atluri S, Jordan S, Albers SL, Pappolla MA, et al. Do regenerative medicine therapies provide longterm relief in chronic low back pain: a systematic review and metaanalysis. Pain Physician 2018;21:515-40.
  45. Schneider BJ, Hunt C, Conger A, Qu W, Maus TP, Vorobeychik Y, et al. The effectiveness of intradiscal biologic treatments for discogenic low back pain: a systematic review. Spine J 2022;22:226-37. https://doi.org/10.1016/j.spinee.2021.07.015
  46. Jain D, Goyal T, Verma N, Paswan AK, Dubey RK. Intradiscal platelet-rich plasma injection for discogenic low back pain and correlation with platelet concentration: a prospective clinical trial. Pain Med 2020;21:2719-25. https://doi.org/10.1093/pm/pnaa254
  47. Baig MZ, Abdullah UE, Muhammad A, Aziz A, Syed MJ, Darbar A. Use of platelet-rich plasma in treating low back pain: a review of the current literature. Asian Spine J 2021;15:117-26. https://doi.org/10.31616/asj.2019.0161
  48. Urits I, Viswanath O, Galasso AC, Sottosani ER, Mahan KM, Aiudi CM, et al. Platelet-rich plasma for the treatment of low back pain: a comprehensive review. Curr Pain Headache Rep 2019;23:52. https://doi.org/10.1007/s11916-019-0797-6
  49. Wu J, Zhou J, Liu C, Zhang J, Xiong W, Lv Y, et al. A prospective study comparing platelet-rich plasma and local anesthetic (LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint syndrome. Pain Pract 2017;17:914-24. https://doi.org/10.1111/papr.12544
  50. Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg 2018;4:115-22. https://doi.org/10.21037/jss.2018.03.04
  51. Nowak Z, Checinski M, Nitecka-Buchta A, Bulanda S, Ilczuk-Rypula D, Postek-Stefanska L, et al. Intramuscular injections and dry needling within masticatory muscles in management of myofascial pain: systematic review of clinical trials. Int J Environ Res Public Health 2021;18:9552. https://doi.org/10.3390/ijerph18189552
  52. Sakalys D, Rokicki JP, Januzis G, Kubilius R. Plasma rich in growth factors injection effectiveness for myofascial pain treatment in masticatory muscles: randomised controlled trial. J Oral Rehabil 2020;47:796-801. https://doi.org/10.1111/joor.12973
  53. Yilmaz O, Sivrikaya EC, Taskesen F, Pirpir C, Ciftci S. Comparison of the efficacy of botulinum toxin, local anesthesia, and platelet-rich plasma injections in patients with myofascial trigger points in the masseter muscle. J Oral Maxillofac Surg 2021;79:88.
  54. Scott A, Docking S, Vicenzino B, Alfredson H, Murphy RJ, Carr AJ, et al. Sports and exercise-related tendinopathies: a review of selected topical issues by participants of the second International Scientific Tendinopathy Symposium (ISTS) Vancouver 2012. Br J Sports Med 2013;47:536-44. https://doi.org/10.1136/bjsports-2013-092329
  55. Li A, Wang H, Yu Z, Zhang G, Feng S, Liu L, et al. Platelet-rich plasma vs corticosteroids for elbow epicondylitis: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e18358. https://doi.org/10.1097/MD.0000000000018358
  56. Arirachakaran A, Sukthuayat A, Sisayanarane T, Laoratanavoraphong S, Kanchanatawan W, Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and networkmeta-analysis. J Orthop Traumatol 2016;17:101-12. https://doi.org/10.1007/s10195-015-0376-5
  57. Tosti R, Jennings J, Sewards JM. Lateral epicondylitis of the elbow. Am J Med 2013;126:357.
  58. Hardy R, Tori A, Fuchs H, Larson T, Brand J, Monroe E. To improve pain and function, platelet-rich plasma injections may be an alternative to surgery for treating lateral epicondylitis: a systematic review. Arthroscopy 2021;37:3360-7. https://doi.org/10.1016/j.arthro.2021.04.043
  59. Galatz LM, Gerstenfeld L, Heber-Katz E, Rodeo SA. Tendon regeneration and scar formation: the concept of scarless healing. J Orthop Res 2015;33:823-31. https://doi.org/10.1002/jor.22853
  60. Chen XT, Fang W, Jones IA, Heckmann ND, Park C, Vangsness CT Jr. The efficacy of platelet-rich plasma for improving pain and function in lateral epicondylitis: a systematic review and meta-analysis with risk-of-bias assessment. Arthroscopy 2021;37:2937-52. https://doi.org/10.1016/j.arthro.2021.04.061
  61. Varshney A, Maheshwari R, Juyal A, Agrawal A, Hayer P. Autologous platelet-rich plasma versus corticosteroid in the management of elbow epicondylitis: a randomized study. Int J Appl Basic Med Res 2017;7:125-8. https://doi.org/10.4103/2229-516X.205808
  62. Kemp JA, Olson MA, Tao MA, Burcal CJ. Platelet-rich plasma versus corticosteroid injection for the treatment of lateral epicondylitis: a systematic review of systematic reviews. Int J Sports Phys Ther 2021;16:597-605.
  63. Muthu S, Patel S, Selvaraj P, Jeyaraman M. Comparative analysis of leucocyte poor vs leucocyte rich platelet-rich plasma in the management of lateral epicondylitis: systematic review & meta-analysis of randomised controlled trials. J ClinOrthop Trauma 2021;19:96-107.
  64. Simental-Mendia M, Vilchez-Cavazos F, Alvarez-Villalobos N, Blazquez-Saldana J, Pena-Martinez V, Villarreal-Villarreal G, et al. Clinical efficacy of platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review and meta-analysis of randomized placebo-controlled clinical trials. Clin Rheumatol 2020;39:2255-65. https://doi.org/10.1007/s10067-020-05000-y
  65. Chen X, Jones IA, Park C, Vangsness CT Jr. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med 2018;46:2020-32. https://doi.org/10.1177/0363546517743746
  66. Ling Y, Wang S. Effects of platelet-rich plasma in the treatment of plantar fasciitis: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2018;97:e12110. https://doi.org/10.1097/md.0000000000012110
  67. Hurley ET, Shimozono Y, Hannon CP, Smyth NA, Murawski CD, Kennedy JG. Platelet-rich plasma versus corticosteroids for plantar fasciitis: a systematic review of randomized controlled trials. Orthop J Sports Med 2020;8:2325967120915704.
  68. Hosny N, Goubran F, BadrEldin Hasan B, Kamel N. Assessment of vascular endothelial growth factor in fresh versus frozen platelet rich plasma. J Blood Transfus 2015;2015:706903. https://doi.org/10.1155/2015/706903
  69. Alkhatib N, Salameh M, Ahmed AF, Alkaramany E, Ahmed G, Mekhaimar MM, et al. Platelet-rich plasma versus corticosteroids in the treatment of chronic plantar fasciitis: a systematic review and meta-analysis of prospective comparative studies. J Foot Ankle Surg 2020;59:546-52. https://doi.org/10.1053/j.jfas.2019.10.003
  70. Fei X, Lang L, Lingjiao H, Wei C, Zhou X. Platelet-rich plasma has better mid-term clinical results than traditional steroid injection for plantar fasciitis: a systematic review and meta-analysis. Orthop Traumatol Surg Res 2021;107:103007. https://doi.org/10.1016/j.otsr.2021.103007
  71. Chiew SK, Ramasamy TS, Amini F. Effectiveness and relevant factors of platelet-rich plasma treatment in managing plantar fasciitis: a systematic review. J Res Med Sci 2016;21:38. https://doi.org/10.4103/1735-1995.183988
  72. Christian RA, Rossy WH, Sherman OH. Patellar tendinopathy: recent developments toward treatment. Bull Hosp Jt Dis (2013) 2014;72:217-24.
  73. Liddle AD, Rodriguez-Merchan EC. Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review. Am J Sports Med 2015;43:2583-90. https://doi.org/10.1177/0363546514560726
  74. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc 2011;19:516-27. https://doi.org/10.1007/s00167-010-1306-y
  75. Tschon M, Fini M, Giardino R, Filardo G, Dallari D, Torricelli P, et al. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 2011;3:96-107. https://doi.org/10.2741/e224
  76. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, et al. Can platelet-rich plasma enhance tendon repair?: a cell culture study. Am J Sports Med 2008;36:1171-8. https://doi.org/10.1177/0363546508314430
  77. Smith J, Sellon JL. Comparing PRP injections with ESWT for athletes with chronic patellar tendinopathy. Clin J Sport Med 2014;24:88-9. https://doi.org/10.1097/JSM.0000000000000063
  78. Dupley L, Charalambous CP. Platelet-rich plasma injections as a treatment for refractory patellar tendinosis: a meta-analysis of randomised trials. Knee Surg Relat Res 2017;29:165-71. https://doi.org/10.5792/ksrr.16.055
  79. Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper's knee in athletes. Am J Sports Med 2013;41:795-803. https://doi.org/10.1177/0363546513475345
  80. Unlu MC, Kivrak A, Kayaalp ME, Birsel O, Akgun I. Peritendinous injection of platelet-rich plasma to treat tendinopathy: a retrospective review. Acta Orthop Traumatol Turc 2017;51:482-7. https://doi.org/10.1016/j.aott.2017.10.003
  81. Fahy KE, Miller EM, Kobayashi Y, Gottschalk AW. Efficacy of platelet-rich plasma on symptom reduction in patellar tendinopathy. Ochsner J 2021;21:232-4. https://doi.org/10.31486/toj.21.0031
  82. Andriolo L, Altamura SA, Reale D, Candrian C, Zaffagnini S, Filardo G. Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med 2019;47:1001-18. https://doi.org/10.1177/0363546518759674
  83. Dadgostar H, Fahimipour F, Pahlevan Sabagh A, Arasteh P, Razi M. Corticosteroids or platelet-rich plasma injections for rotator cuff tendinopathy: a randomized clinical trial study. J Orthop Surg Res 2021;16:333. https://doi.org/10.1186/s13018-021-02470-x
  84. Dickinson RN, Ayers GD, Archer KR, Fan R, Page C, Higgins LD, et al. Physical therapy versus natural history in outcomes of rotator cuff tears: the Rotator Cuff Outcomes Workgroup (ROW) cohort study. J Shoulder Elbow Surg 2019;28:833-8. https://doi.org/10.1016/j.jse.2018.10.001
  85. Lo IK, Denkers MR, More KD, Nelson AA, Thornton GM, Boorman RS. Partial-thickness rotator cuff tears: clinical and imaging outcomes and prognostic factors of successful nonoperative treatment. Open Access J Sports Med 2018;9:191-7. https://doi.org/10.2147/OAJSM.S153236
  86. Lin MT, Chiang CF, Wu CH, Huang YT, Tu YK, Wang TG. Comparative effectiveness of injection therapies in rotator cuff tendinopathy: a systematic review, pairwise and network meta-analysis of randomized controlled trials. Arch Phys Med Rehabil 2019;100:336-49. https://doi.org/10.1016/j.apmr.2018.06.028
  87. Zhou Y, Wang JH. PRP treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int 2016;2016:9103792.
  88. Chen X, Jones IA, Togashi R, Park C, Vangsness CT Jr. Use of platelet-rich plasma for the improvement of pain and function in rotator cuff tears: a systematic review and meta-analysis with bias assessment. Am J Sports Med 2020;48:2028-41. https://doi.org/10.1177/0363546519881423
  89. A Hamid MS, Sazlina SG. Platelet-rich plasma for rotator cuff tendinopathy: a systematic review and meta-analysis. PLoS One 2021;16:e0251111. https://doi.org/10.1371/journal.pone.0251111
  90. Giovannetti de Sanctis E, Franceschetti E, De Dona F, Palumbo A, Paciotti M, Franceschi F. The efficacy of injections for partial rotator cuff tears: a systematic review. J Clin Med 2020;10:51. https://doi.org/10.3390/jcm10010051
  91. Lin MT, Wei KC, Wu CH. Effectiveness of platelet-rich plasma injection in rotator cuff tendinopathy: a systematic review and meta-analysis of randomized controlled trials. Diagnostics (Basel) 2020;10:189. https://doi.org/10.3390/diagnostics10040189
  92. Kelley MJ, McClure PW, Leggin BG. Frozen shoulder: evidence and a proposed model guiding rehabilitation. J Orthop Sports Phys Ther 2009;39:135-48. https://doi.org/10.2519/jospt.2009.2916
  93. Thu AC, Kwak SG, Shein WN, Htun M, Htwe TT, Chang MC. Comparison of ultrasound-guided platelet-rich plasma injection and conventional physical therapy for management of adhesive capsulitis: a randomized trial. J Int Med Res 2020;48:300060520976032.
  94. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007;78:661-9. https://doi.org/10.1902/jop.2007.060302
  95. Karabas C, Talay Calis H, Topaloglu US, Karakukcu C. Effects of platelet-rich plasma injection on pain, range of motion, and disability in adhesive capsulitis: a prospective, randomized-controlled study. Turk J Phys Med Rehabil 2021;67:462-72. https://doi.org/10.5606/tftrd.2021.6690
  96. Barman A, Mukherjee S, Sahoo J, Maiti R, Rao PB, Sinha MK, et al. Single intra-articular platelet-rich plasma versus corticosteroid injections in the treatment of adhesive capsulitis of the shoulder: a cohort study. Am J Phys Med Rehabil 2019;98:549-57. https://doi.org/10.1097/PHM.0000000000001144
  97. Shahzad HF, Taqi M, Gillani SF, Masood F, Ali M. Comparison of functional outcome between intra-articular injection of corticosteroid versus platelet-rich plasma in frozen shoulder: a randomized controlled trial. Cureus 2021;13:e20560.
  98. Kearney RS, Ji C, Warwick J, Parsons N, Brown J, Harrison P, et al. Effect of platelet-rich plasma injection vs sham injection on tendon dysfunction in patients with chronic midportion Achilles tendinopathy: a randomized clinical trial. JAMA 2021;326:137-44. https://doi.org/10.1001/jama.2021.6986
  99. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev 2014;2014:CD010071.